Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate

  • Marga Nijenhuis*
  • , Bianca Soree
  • , Wafa O.M. Jama
  • , Nienke J. de Boer-Veger
  • , Anne Marie Buunk
  • , Henk Jan Guchelaar
  • , Elisa J.F. Houwink
  • , Gerard A. Rongen
  • , Ron H.N. van Schaik
  • , Jesse J. Swen
  • , Daan Touw
  • , Jan van der Weide
  • , Roos van Westrhenen
  • , Vera H.M. Deneer
  • , Arne Risselada
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science